Genmab | Capitale Di Prestito



Loan Capital Cambiamento Data
Agios Pharmaceuticals USD 0 0 2024-12
Almirall EUR 351.76M 538K 2024-06
Amarin USD 0 0 2024-09
Amgen USD 56.55B 305M 2024-12
AstraZeneca USD 27.89B 154M 2025-03
Bayer EUR 34.55B 2.12B 2024-12
BioMarin Pharmaceutical USD 595.89M 1.27M 2024-12
Demant DKK 14.59B 1.4B 2024-12
Exelixis USD 0 0 2025-01
Fresenius Medical Care EUR 9.76B 202.37M 2024-12
Galapagos EUR 7.79M 453K 2025-03
Genmab DKK 937M 41M 2024-12
GlaxoSmithKline GBP 16.47B 1.84B 2025-03
GN Store Nord DKK 8.76B 640M 2025-03
GRIFOLS EUR 8.68B 155.99M 2024-12
Hikma Pharmaceutical USD 1.06B 31M 2024-06
Insmed USD 1.13B 147.77M 2024-12
Lonza CHF 4.24B 602M 2024-12
Merck EUR 6.37B 1.51B 2024-12
Novartis USD 22.93B 2.41B 2024-12
Regeneron Pharmaceuticals USD 2.7B 400K 2025-03
Roche Holding CHF 32.1B 1.94B 2024-12
Sanofi 13.41B 1.62B 2025-03
UCB EUR 2.82B 166M 2024-12



Genmab Capitale Di Prestito - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - May 2025.